Approvals/CIMA-AEMPS/PSYLIPAX 100 MG+150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG

Approved

STANDARD

PSYLIPAX 100 MG+150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG

Exeltis Healthcare S.L.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 277196bba512490c
Drug Cima Aemps Name: PSYLIPAX 100 MG+150 MG SUSPENSION INYECTABLE DE LIBERACION PROLONGADA EN JERINGA PRECARGADA EFG
Register Number: 90627
Holder Company Name: Exeltis Healthcare S.L.
Marketing Company Name: Exeltis Healthcare S.L.
Authorization Date: 2025-10-07
Dosage Form: SUSPENSIÓN INYECTABLE DE LIBERACIÓN PROLONGADA EN JERINGA PRECARGADA
Dose: 100 mg + 150 mg
Route Of Administration: VÍA INTRAMUSCULAR
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Exeltis Healthcare S.L.

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 7, 2025

Approval ID

277196bba512490c

Type

Standard